# Neuclare Device for Temporary Improvement of Executive Function in Patients With Mild Cognitive Impairment and Prodromal Alzheimer's Disease

> **NCT07239310** · NA · RECRUITING · sponsor: **Deepsonbio** · enrollment: 138 (estimated)

## Conditions studied

- Mild Cognitive Impairment
- Alzheimer's Disease(AD)

## Interventions

- **DEVICE:** Participants receive Neuclare Device while continuing their cognitive medication
- **DEVICE:** Participants receive Sham Neuclare Device while continuing their cognitive medication

## Key facts

- **NCT ID:** NCT07239310
- **Lead sponsor:** Deepsonbio
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-20
- **Primary completion:** 2026-06
- **Final completion:** 2026-07
- **Target enrollment:** 138 (ESTIMATED)
- **Last updated:** 2025-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07239310

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07239310, "Neuclare Device for Temporary Improvement of Executive Function in Patients With Mild Cognitive Impairment and Prodromal Alzheimer's Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07239310. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*